Top

05-03-2025 | Urology – Original Paper

Clinical predictors of bladder outlet obstruction in men consulting for routine urological screening

Authors: Massimiliano Raffo, Paolo Capogrosso, Edoardo Pozzi, Federico Belladelli, Christian Corsini, Alessandro Bertini, Fausto Negri, Luigi Candela, Alessandro Larcher, Rayan Matloob, Alessia d’Arma, Francesco Montorsi, Andrea Salonia

Published in: International Urology and Nephrology

Abstract

Purpose

Lower urinary tract symptoms (LUTS) associated with bladder outlet obstruction (BOO) are prevalent among men, notwithstanding being self-underreported. We aimed to assess the predictors for BOO during first visit.

Methods

Data from 1045 analyzed men older than 40 years attending a single urological institution from 2010 to 2021. The men diagnosed with BOO, prostate cancer or any treatment for BOO were excluded. The patients completed the International Prostatic Symptoms Score (IPSS) and were investigated with prostate-specific antigen (PSA), trans-rectal ultrasound to measure prostate volume (PV) and free uroflowmetry. Logistic regression analysis tested the association between parameters and BOO. The area under the curve compared the diagnostic accuracy of predictors. The Youden-index analysis defined the cut-off predicting LUTS.

Results

Of 1045 patients, the median (IQR) age was 62 (51–69) years. A total of 773 (74%) had moderate LUTS. Both PV (OR: 1.16; 95%CI 1.04–1.3; p = 0.005) and IPSS (OR: 1.06; 95%CI 1.03–1.08; p < 0.001) were associated with BOO after adjusting for age. They showed a predictive accuracy with an AUC of 0.69 (0.60–0.77) and 0.63 (0.59–0.67) for PV and IPSS, respectively. A PV of 43 mL emerged as the cut-off point to define the risk of BOO. Therefore, a 60-year man with a PV ≥ 43 mL showed an 84% (70–90) risk of BOO as compared with 59% (50–68) for a same age man with lower PV.

Conclusion

Men older than 40 years should be screened for LUTS associated with BOO since they are highly prevalent. User-friendly parameters such as PV and IPSS could guide further investigation of BOO.

Gammack JK (2010) Lower urinary tract symptoms. Clin Geriatr Med 26:249–260. https://doi.org/10.1016/j.cger.2010.02.006CrossRefPubMed

Dmochowski RR (2005) Bladder outlet obstruction: etiology and evaluation. Rev Urol 7(Suppl 6):S3-13PubMedPubMedCentral

Schäfer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A et al (2002) Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 21:261–274. https://doi.org/10.1002/nau.10066CrossRefPubMed

Hald T (1989) Urodynamics in benign prostatic hyperplasia: a survey. Prostate Suppl 2:69–77. https://doi.org/10.1002/pros.2990150508CrossRefPubMed

Abrams P, Chapple C, Khoury S, Roehrborn C, de la Rosette J (2013) International consultation on new developments in prostate cancer and prostate diseases evaluation and treatment of lower urinary tract symptoms in older men. J Urol. https://doi.org/10.1016/j.juro.2012.11.021CrossRefPubMed

Klingler HC, Madersbacher S, Djavan B, Schatzl G, Marberger M, Schmidbauer CP (1998) Morbidity of the evaluation of the lower urinary tract with transurethral multichannel pressure-flow studies. J Urol 159:191–194. https://doi.org/10.1016/s0022-5347(01)64054-0CrossRefPubMed

Abdel-Aal A, El-Karamany T, Al-Adl AM, Abdel-Wahab O, Farouk H (2011) Assessment of noninvasive predictors of bladder outlet obstruction and acute urinary retention secondary to benign prostatic enlargement. Arab J Urol 9:209–214. https://doi.org/10.1016/j.aju.2011.09.003CrossRefPubMedPubMedCentral

Lee YJ, Lee JK, Kim JJ, Lee HM, Oh JJ, Lee S et al (2019) Development and validation of a clinical nomogram predicting bladder outlet obstruction via routine clinical parameters in men with refractory nonneurogenic lower urinary tract symptoms. Asian J Androl 21:486–492. https://doi.org/10.4103/aja.aja_127_18CrossRefPubMedPubMedCentral

Reynard JM, Abrams P (1995) Bladder-outlet obstruction–assessment of symptoms. World J Urol 13:3–8. https://doi.org/10.1007/BF00182657CrossRefPubMed

10.

van Venrooij GE, Boon TA, de Gier RP (1995) International prostate symptom score and quality of life assessment versus urodynamic parameters in men with benign prostatic hyperplasia symptoms. J Urol 153:1516–1519. https://doi.org/10.1097/00005392-199505000-00046CrossRefPubMed

11.

Roffman CE, Buchanan J, Allison GT (2016) Charlson comorbidities index. J Physiother 62:171. https://doi.org/10.1016/j.jphys.2016.05.008CrossRefPubMed

12.

Gratzke C, Bachmann A, Descazeaud A, Drake MJ, Madersbacher S, Mamoulakis C et al (2015) EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 67:1099–1109. https://doi.org/10.1016/j.eururo.2014.12.038CrossRefPubMed

13.

Hosmer DW, Lemeshow S, Sturdivant RX (2013) Applied Logistic Regression, 3rd edn. Wiley, HobokenCrossRef

14.

Swets JA (1988) Measuring the accuracy of diagnostic systems. Science 240:1285–1293. https://doi.org/10.1126/science.3287615CrossRefPubMed

15.

Griffiths CJ, Harding C, Blake C, McIntosh S, Drinnan MJ, Robson WA et al (2005) A nomogram to classify men with lower urinary tract symptoms using urine flow and noninvasive measurement of bladder pressure. J Urol 174:1323–6. https://doi.org/10.1097/01.ju.0000173637.07357.9eCrossRefPubMed

16.

Oelke M, Höfner K, Jonas U, de la Rosette JJ, Ubbink DT, Wijkstra H (2007) Diagnostic accuracy of noninvasive tests to evaluate bladder outlet obstruction in men: detrusor wall thickness, uroflowmetry, postvoid residual urine, and prostate volume. Eur Urol 52:827–834. https://doi.org/10.1016/j.eururo.2006.12.023CrossRefPubMed

17.

Franco G, De Nunzio C, Leonardo C, Tubaro A, Ciccariello M, De Dominicis C et al (2010) Ultrasound assessment of intravesical prostatic protrusion and detrusor wall thickness–new standards for noninvasive bladder outlet obstruction diagnosis? J Urol 183:2270–2274. https://doi.org/10.1016/j.juro.2010.02.019CrossRefPubMed

18.

Yurt M, Süer E, Gülpinar O, Telli O, Arikan N (2012) Diagnosis of bladder outlet obstruction in men with lower urinary tract symptoms: comparison of near infrared spectroscopy algorithm and pressure flow study in a prospective study. Urology 80:182–186. https://doi.org/10.1016/j.urology.2012.03.022CrossRefPubMed

19.

Steele GS, Sullivan MP, Sleep DJ, Yalla SV (2000) Combination of symptom score, flow rate and prostate volume for predicting bladder outflow obstruction in men with lower urinary tract symptoms. J Urol 164:344–348CrossRefPubMed

20.

De Nunzio C, Autorino R, Bachmann A, Briganti A, Carter S, Chun F et al (2016) The diagnosis of benign prostatic obstruction: development of a clinical nomogram. Neurourol Urodyn 35:235–240. https://doi.org/10.1002/nau.22705CrossRefPubMed

21.

Bailey K, Abrams P, Blair PS, Chapple C, Glazener C, Horwood J et al (2015) Urodynamics for prostate surgery trial; randomised evaluation of assessment methods (UPSTREAM) for diagnosis and management of bladder outlet obstruction in men: study protocol for a randomised controlled trial. Trials 16:567. https://doi.org/10.1186/s13063-015-1087-1CrossRefPubMedPubMedCentral

22.

Young GJ, Metcalfe C, Lane JA, Lewis AL, Abrams P, Blair PS et al (2022) Prostate surgery for men with lower urinary tract symptoms: do we need urodynamics to find the right candidates? exploratory findings from the UPSTREAM trial. Eur Urol Focus 8:1331–1339. https://doi.org/10.1016/j.euf.2021.11.010CrossRefPubMedPubMedCentral

23.

Yalla SV, Sullivan MP, Lecamwasam HS, DuBeau CE, Vickers MA, Cravalho EG (1995) Correlation of American urological association symptom index with obstructive and nonobstructive prostatism. J Urol 153:674–9CrossRefPubMed

24.

Laniado ME, Ockrim JL, Marronaro A, Tubaro A, Carter SS (2004) Serum prostate-specific antigen to predict the presence of bladder outlet obstruction in men with urinary symptoms. BJU Int 94:1283–1286. https://doi.org/10.1111/j.1464-410X.2004.05158.xCrossRefPubMed

25.

Belal M, Abrams P (2006) Noninvasive methods of diagnosing bladder outlet obstruction in men part 1 nonurodynamic approach. J Urol 176:22–8. https://doi.org/10.1016/S0022-5347(06)00569-6CrossRefPubMed

26.

Eckhardt MD, van Venrooij GE, Boon TA (2001) Interactions between prostate volume, filling cystometric estimated parameters, and data from pressure-flow studies in 565 men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Neurourol Urodyn 20:579–590. https://doi.org/10.1002/nau.1010CrossRefPubMed

27.

Rademakers K, Drake MJ, Gammie A, Djurhuus JC, Rosier PFWM, Abrams P et al (2017) Male bladder outlet obstruction: time to re-evaluate the definition and reconsider our diagnostic pathway? ICI-RS 2015. Neurourol Urodyn 36:894–901. https://doi.org/10.1002/nau.23178CrossRefPubMed

28.

Lim KB, Ho H, Foo KT, Wong MYC, Fook-Chong S (2006) Comparison of intravesical prostatic protrusion, prostate volume and serum prostatic-specific antigen in the evaluation of bladder outlet obstruction. Int J Urol Off J Jpn Urol Assoc 13:1509–1513. https://doi.org/10.1111/j.1442-2042.2006.01611.xCrossRef

29.

Rosier PF, de la Rosette JJ (1995) Is there a correlation between prostate size and bladder-outlet obstruction? World J Urol 13:9–13. https://doi.org/10.1007/BF00182658CrossRefPubMed

30.

Chia SJ, Heng CT, Chan SP, Foo KT (2003) Correlation of intravesical prostatic protrusion with bladder outlet obstruction. BJU Int 91:371–374. https://doi.org/10.1046/j.1464-410x.2003.04088.xCrossRefPubMed

31.

Mangat R, Ho HSS, Kuo TLC (2018) Non-invasive evaluation of lower urinary tract symptoms (LUTS) in men. Asian J Urol 5:42–47. https://doi.org/10.1016/j.ajur.2017.12.002CrossRefPubMed

32.

Kim M, Cheeti A, Yoo C, Choo M, Paick J-S, Oh S-J (2014) Non-invasive clinical parameters for the prediction of urodynamic bladder outlet obstruction: analysis using causal Bayesian networks. PLoS ONE 9:e113131. https://doi.org/10.1371/journal.pone.0113131CrossRefPubMedPubMedCentral

33.

Madersbacher S, Klingler HC, Djavan B, Stulnig T, Schatzl G, Schmidbauer CP et al (1997) Is obstruction predictable by clinical evaluation in patients with lower urinary tract symptoms? Br J Urol 80:72–77. https://doi.org/10.1046/j.1464-410x.1997.00220.xCrossRefPubMed

34.

Tanaka Y, Masumori N, Itoh N, Tsukamoto T, Furuya S (2001) Ogura H [The prediction of bladder outlet obstruction with prostate volume, maximum flow rate, residual urine and the international prostate symptom score in patients with lower urinary tract symptoms]. Hinyokika Kiyo 47:843–847PubMed

35.

Ahmed A, Farhan B, Vernez S, Ghoniem GM (2016) The challenges in the diagnosis of detrusor underactivity in clinical practice: a mini-review. Arab J Urol 14:223–227. https://doi.org/10.1016/j.aju.2016.06.005CrossRefPubMedPubMedCentral

Title: Clinical predictors of bladder outlet obstruction in men consulting for routine urological screening
Authors: Massimiliano Raffo
Paolo Capogrosso
Edoardo Pozzi
Federico Belladelli
Christian Corsini
Alessandro Bertini
Fausto Negri
Luigi Candela
Alessandro Larcher
Rayan Matloob
Alessia d’Arma
Francesco Montorsi
Andrea Salonia
Publication date: 05-03-2025
Publisher: Springer Netherlands
Published in: International Urology and Nephrology
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-025-04432-2

Keynote webinar | Spotlight on advances in lupus

Live
Webinar | 27-05-2025 | 18:00 (CEST)

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Join this session to learn more about novel biomarkers for diagnosis and monitoring and familiarise yourself with current and emerging targeted therapies.

Join us live: Tuesday 27th May, 18:00-19:15 (CEST)

Prof. Edward Vital

Prof. Ronald F. van Vollenhoven

Developed by: Springer Medicine

Elevate your expertise in aplastic anemia (Link opens in a new window)

Aplastic Anemia
Independent Medical Education

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases.

Supported by:

Pfizer

Developed by: Springer Healthcare IME

Learn more

Keynote webinar | Spotlight on advances in lupus

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Keynote webinar | Spotlight on advances in lupus

Elevate your expertise in aplastic anemia (Link opens in a new window)